RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Relay Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$17.09+0.81 (+4.98%)
Close on Oct 19, 2026
- Market cap
- $3.47B
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$15.36MFY2025, -28.6% a year since FY2020